BGM Group (BGM) Competitors $8.60 +0.14 (+1.65%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$8.26 -0.34 (-4.01%) As of 08/1/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock BGM vs. SRRK, ACLX, ACAD, PTCT, VKTX, SWTX, MLTX, PTGX, AAPG, and IMVTShould you be buying BGM Group stock or one of its competitors? The main competitors of BGM Group include Scholar Rock (SRRK), Arcellx (ACLX), ACADIA Pharmaceuticals (ACAD), PTC Therapeutics (PTCT), Viking Therapeutics (VKTX), SpringWorks Therapeutics (SWTX), MoonLake Immunotherapeutics (MLTX), Protagonist Therapeutics (PTGX), Ascentage Pharma Group International (AAPG), and Immunovant (IMVT). These companies are all part of the "pharmaceutical products" industry. BGM Group vs. Its Competitors Scholar Rock Arcellx ACADIA Pharmaceuticals PTC Therapeutics Viking Therapeutics SpringWorks Therapeutics MoonLake Immunotherapeutics Protagonist Therapeutics Ascentage Pharma Group International Immunovant BGM Group (NASDAQ:BGM) and Scholar Rock (NASDAQ:SRRK) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation. Do institutionals & insiders believe in BGM or SRRK? 91.1% of Scholar Rock shares are owned by institutional investors. 58.7% of BGM Group shares are owned by company insiders. Comparatively, 13.3% of Scholar Rock shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is BGM or SRRK more profitable? BGM Group's return on equity of 0.00% beat Scholar Rock's return on equity.Company Net Margins Return on Equity Return on Assets BGM GroupN/A N/A N/A Scholar Rock N/A -118.22%-82.01% Which has stronger earnings and valuation, BGM or SRRK? BGM Group has higher earnings, but lower revenue than Scholar Rock. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBGM Group$25.10M33.31-$1.44MN/AN/AScholar Rock$33.19M104.02-$246.29M-$2.53-14.37 Which has more volatility & risk, BGM or SRRK? BGM Group has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Scholar Rock has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Does the media prefer BGM or SRRK? In the previous week, Scholar Rock had 5 more articles in the media than BGM Group. MarketBeat recorded 5 mentions for Scholar Rock and 0 mentions for BGM Group. Scholar Rock's average media sentiment score of 0.90 beat BGM Group's score of 0.00 indicating that Scholar Rock is being referred to more favorably in the news media. Company Overall Sentiment BGM Group Neutral Scholar Rock Positive Do analysts rate BGM or SRRK? Scholar Rock has a consensus target price of $44.14, indicating a potential upside of 21.40%. Given Scholar Rock's stronger consensus rating and higher possible upside, analysts plainly believe Scholar Rock is more favorable than BGM Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BGM Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Scholar Rock 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 SummaryScholar Rock beats BGM Group on 9 of the 14 factors compared between the two stocks. Get BGM Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricBGM GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$822.50M$3.00B$5.49B$9.54BDividend YieldN/A2.43%4.73%4.09%P/E RatioN/A17.7428.8323.83Price / Sales33.31179.21372.0766.02Price / CashN/A41.9535.4557.96Price / Book1.178.508.275.54Net Income-$1.44M-$55.06M$3.25B$259.28M7 Day Performance-17.70%-3.99%-3.73%-4.68%1 Month Performance-11.89%9.58%4.29%4.36%1 Year PerformanceN/A6.70%25.87%17.88% BGM Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMBGM GroupN/A$8.60+1.7%N/AN/A$822.50M$25.10M0.00298SRRKScholar Rock3.8123 of 5 stars$40.77-0.9%$42.67+4.7%+301.3%$3.88B$33.19M-16.17140News CoveragePositive NewsUpcoming EarningsAnalyst ForecastACLXArcellx2.6029 of 5 stars$67.68-2.5%$111.23+64.4%+21.3%$3.75B$107.94M-22.7580News CoveragePositive NewsAnalyst ForecastACADACADIA Pharmaceuticals3.9847 of 5 stars$22.270.0%$27.88+25.2%+23.9%$3.73B$996.28M16.28510News CoverageUpcoming EarningsAnalyst RevisionPTCTPTC Therapeutics4.4836 of 5 stars$46.70-2.4%$65.00+39.2%+59.5%$3.72B$1.77B7.221,410Trending NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionVKTXViking Therapeutics3.8708 of 5 stars$32.03+0.3%$87.15+172.1%-40.2%$3.59BN/A-27.7820Short Interest ↑SWTXSpringWorks TherapeuticsN/A$46.99flat$52.57+11.9%N/A$3.54B$191.59M-13.78230Upcoming EarningsMLTXMoonLake Immunotherapeutics2.721 of 5 stars$53.35-0.4%$74.50+39.7%+25.9%$3.41BN/A-23.202News CoveragePositive NewsUpcoming EarningsPTGXProtagonist Therapeutics2.1526 of 5 stars$54.88-0.6%$66.10+20.4%+41.8%$3.41B$207.80M73.41120Positive NewsUpcoming EarningsAAPGAscentage Pharma Group InternationalN/A$39.10-1.5%N/AN/A$3.41B$134.35M0.00600IMVTImmunovant1.6706 of 5 stars$18.04+1.9%$36.30+101.2%-45.6%$3.09BN/A-6.60120Upcoming Earnings Related Companies and Tools Related Companies SRRK Competitors ACLX Competitors ACAD Competitors PTCT Competitors VKTX Competitors SWTX Competitors MLTX Competitors PTGX Competitors AAPG Competitors IMVT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BGM Group Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BGM Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
